🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/12/1992 | 0,1193 USD |
| 31/08/1992 | 0,1193 USD |
| 02/06/1992 | 0,1097 USD |
| 02/03/1992 | 0,1097 USD |
| 02/12/1991 | 0,1002 USD |
| 30/08/1991 | 0,1002 USD |
| 03/06/1991 | 0,0891 USD |
| 04/03/1991 | 0,0891 USD |
| 03/12/1990 | 0,0891 USD |
| 28/08/1990 | 0,0891 USD |
| 29/05/1990 | 0,0716 USD |
| 05/03/1990 | 0,0716 USD |
| 04/12/1989 | 0,0716 USD |
| 29/08/1989 | 0,0716 USD |
| 30/05/1989 | 0,0652 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/04/2004 | 43,32 | 43,34 | 42,35 | 43,22 | +0,51% | 2,29% | 4.897.618 |
| 02/04/2004 | 43,51 | 43,65 | 42,55 | 43,00 | +0,60% | 2,54% | 7.634.261 |
| 01/04/2004 | 42,51 | 43,18 | 42,41 | 42,74 | +1,36% | 1,80% | 6.060.479 |
| 31/03/2004 | 42,18 | 42,45 | 41,94 | 42,17 | +0,20% | 1,22% | 10.088.153 |
| 30/03/2004 | 42,44 | 42,51 | 41,79 | 42,08 | -1,05% | 1,69% | 7.722.817 |
| 29/03/2004 | 42,27 | 42,62 | 41,94 | 42,53 | +1,30% | 1,63% | 5.698.081 |
| 26/03/2004 | 41,75 | 42,42 | 41,68 | 41,98 | +0,71% | 1,78% | 5.871.734 |
| 25/03/2004 | 41,36 | 41,97 | 41,13 | 41,69 | +1,58% | 2,03% | 8.132.794 |
| 24/03/2004 | 41,89 | 42,10 | 40,89 | 41,04 | -2,14% | 2,89% | 8.837.050 |
| 23/03/2004 | 41,70 | 42,15 | 41,67 | 41,94 | +0,85% | 1,14% | 6.212.125 |
| 22/03/2004 | 41,72 | 42,13 | 41,39 | 41,58 | -0,43% | 1,76% | 10.136.046 |
| 19/03/2004 | 42,54 | 42,73 | 41,76 | 41,77 | -1,79% | 2,29% | 8.308.858 |
| 18/03/2004 | 42,32 | 42,70 | 42,05 | 42,53 | +0,41% | 1,53% | 7.997.707 |
| 17/03/2004 | 43,23 | 43,30 | 42,08 | 42,36 | -1,60% | 2,83% | 11.958.518 |
| 16/03/2004 | 43,15 | 43,16 | 42,81 | 43,04 | +0,58% | 0,82% | 6.689.803 |
| 15/03/2004 | 43,27 | 43,32 | 42,74 | 42,80 | -0,66% | 1,35% | 7.222.711 |
| 12/03/2004 | 43,01 | 43,22 | 42,88 | 43,08 | +0,36% | 0,78% | 6.929.586 |
| 11/03/2004 | 43,65 | 44,80 | 42,76 | 42,93 | -2,51% | 4,68% | 9.375.513 |
| 10/03/2004 | 44,87 | 44,98 | 43,94 | 44,04 | -2,39% | 2,32% | 9.885.050 |
| 09/03/2004 | 45,28 | 45,41 | 44,99 | 45,11 | -0,82% | 0,93% | 6.222.814 |
| 08/03/2004 | 46,04 | 46,04 | 45,47 | 45,49 | -0,89% | 1,24% | 4.883.366 |
| 05/03/2004 | 45,28 | 46,07 | 45,17 | 45,90 | +0,67% | 1,98% | 6.340.610 |
| 04/03/2004 | 45,53 | 45,90 | 45,45 | 45,59 | +1,42% | 0,98% | 6.640.338 |
| 03/03/2004 | 45,13 | 45,23 | 44,67 | 44,95 | -1,34% | 1,25% | 7.498.964 |
| 02/03/2004 | 46,20 | 46,21 | 45,32 | 45,56 | -1,44% | 1,92% | 10.426.028 |
| 01/03/2004 | 46,20 | 46,37 | 45,85 | 46,23 | +0,77% | 1,14% | 5.237.904 |
| 27/02/2004 | 45,82 | 46,40 | 45,65 | 45,88 | +0,92% | 1,65% | 7.618.750 |
| 26/02/2004 | 45,28 | 45,62 | 45,26 | 45,46 | -0,52% | 0,80% | 7.477.794 |
| 25/02/2004 | 46,28 | 46,43 | 45,50 | 45,70 | -1,26% | 2,02% | 8.946.252 |
| 24/02/2004 | 46,32 | 46,39 | 46,03 | 46,28 | -0,08% | 0,78% | 5.724.805 |